RESUMEN
An approximately 38-year-old captive male lesser flamingo (Phoeniconaias minor) was presented with a mass involving the right ventral gnathotheca. The mass was surgically excised after which the flamingo was treated with parenteral nonsteroidal anti-inflammatory and antibiotic drugs. Histological analysis identified an abscess with intralesional fungal organisms. Culture and polymerase chain reaction sequencing identified the fungal organisms within the lesion as Candida albicans. Treatment with oral itraconazole was initiated 23 days after initial surgical excision; however, the flamingo continued to lose weight while being treated, and died after 10 days of antifungal therapy. Necropsy, histologic examination, and culture confirmed the persistence of a mycotic abscess that infiltrated the mandibular bone and was associated with C albicans.
Asunto(s)
Candidiasis , Animales , Antifúngicos/uso terapéutico , Aves , Candidiasis/tratamiento farmacológico , Candidiasis/veterinaria , Itraconazol/uso terapéutico , MasculinoRESUMEN
Antimicrobial resistance (AMR) in pathogens important to aquatic animal health is of increasing concern but vastly understudied. Antimicrobial therapy is used to both treat and prevent bacterial disease in fish and is critical for a viable aquaculture industry and for maintenance of wild fish populations. Unfortunately, phenotypic antimicrobial susceptibility testing is technically difficult for bacteria recovered from aquatic animal hosts resulting in challenges in resistance monitoring using traditional methods. Whole-genome sequencing provides an appealing methodology for investigation of putative resistance. As part of the ongoing efforts of the FDA CVM Vet-LIRN to monitor AMR, source laboratories cultured and preliminarily identified pathogenic bacteria isolated from various fish species collected in 2019 from across the United States. Sixty-one bacterial isolates were evaluated using whole-genome sequencing. We present here the assembled draft genomes, AMR genes, predicted resistance phenotypes, and virulence factors of the 61 isolates and discuss concurrence of the identifications made by source laboratories using matrix-assisted laser desorption/time-of-flight mass spectrometry.
Asunto(s)
Antibacterianos , Bacterias , Farmacorresistencia Bacteriana , Enfermedades de los Peces , Genoma Bacteriano , Animales , Farmacorresistencia Bacteriana/genética , Enfermedades de los Peces/microbiología , Antibacterianos/farmacología , Bacterias/efectos de los fármacos , Bacterias/genética , Bacterias/aislamiento & purificación , Peces/microbiología , Secuenciación Completa del Genoma , Pruebas de Sensibilidad Microbiana/veterinariaRESUMEN
In 2018, Mycoplasma ovipneumoniae was detected in free-ranging caribou (Rangifer tarandus grantii) and Dall's sheep (Ovis dalli dalli) in Alaska, US. Evaluation of additional nasal swabs and archived tissues for M. ovipneumoniae suggested that this bacterium was widespread geographically and temporally in populations of both species. Multilocus sequence typing of four loci identified a single, novel, apparently stable strain type of M. ovipneumoniae in 11 Dall's sheep and 15 caribou in multiple populations across Alaska sampled over a period of 15 yr (2004-19). This strain type differs from those detected to date from wild or domestic sheep (Ovis aries) or goats (Capra aegagrus hircus) tested in Alaska or the lower 48 states. Although the population health implications of this strain are unknown, it has not been associated with population-wide mortality events. The presence of this strain does not decrease the potential risk from the introduction of a pathogenic M. ovipneumoniae strain associated with severe disease in other wildlife populations; therefore, continued monitoring for signs of disease and additional strains is important.